Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
28 Nov 2017 07:00 AM
RNS
Parsortix enables CTC molecular characterisation
23 Nov 2017 07:00 AM
RNS
PHILIPS COLLABORATION IN BREAST AND RECTAL CANCER
17 Nov 2017 04:06 PM
RNS
Holding(s) in Company
16 Nov 2017 08:23 AM
RNS
Total Voting Rights and Covington Subscription
06 Nov 2017 07:00 AM
RNS
Holding(s) in Company
06 Nov 2017 07:00 AM
RNS
Holding(s) in Company
06 Nov 2017 07:00 AM
RNS
Holding(s) in Company
02 Nov 2017 10:04 AM
RNS
Holding(s) in Company
01 Nov 2017 08:12 AM
RNS
ANGLE: Completion of Fundraising and Acquisition
31 Oct 2017 02:18 PM
RNS
Result of AGM
30 Oct 2017 10:31 AM
RNS
Result of General Meeting
26 Oct 2017 08:10 AM
RNS
Total Voting Rights
23 Oct 2017 07:00 AM
RNS
Parsortix harvests cancer cells from bone marrow
20 Oct 2017 03:05 PM
RNS
Notice of AGM
17 Oct 2017 07:00 AM
RNS
ANGLE: 7th Peer Reviewed Publication On Parsortix
12 Oct 2017 07:00 AM
RNS
Proposed further subscription for £2.8 million
09 Oct 2017 07:02 AM
RNS
CTCs harvested with Parsortix grown in laboratory
09 Oct 2017 07:01 AM
RNS
Potential new analytical protocol using Parsortix
09 Oct 2017 07:00 AM
RNS
Parsortix Showcased at CTC Conference
05 Oct 2017 11:46 AM
RNS
Results of Fundraising
05 Oct 2017 07:00 AM
RNS
Acquisition and Fundraising
13 Sep 2017 05:36 PM
RNS
Holding(s) in Company
13 Sep 2017 07:00 AM
RNS
Exclusive worldwide option over megakaryocyte IP
11 Sep 2017 07:00 AM
RNS
Co-Marketing Partnership with QIAGEN
05 Sep 2017 07:00 AM
RNS
Change of Adviser
04 Sep 2017 07:00 AM
RNS
New Research with Parsortix
27 Jul 2017 07:00 AM
RNS
Preliminary Results
20 Jul 2017 01:00 PM
RNS
Preclinical Study Presented At Tumor Boston Summit
06 Jul 2017 10:05 AM
RNS
Notice of Results
04 Jul 2017 07:00 AM
RNS
Successful Headline Data in Ovarian Cancer Studies
15 Jun 2017 07:00 AM
RNS
Parsortix breakthrough in prostate cancer
05 Jun 2017 07:00 AM
RNS
Success with Parsortix in Colorectal Cancer
03 May 2017 07:00 AM
RNS
Business Update
04 Apr 2017 07:00 AM
RNS
Holding(s) in Company
03 Apr 2017 07:00 AM
RNS
Parsortix enables analysis in head and neck cancer
30 Mar 2017 07:00 AM
RNS
Prostate Cancer Update
13 Feb 2017 07:00 AM
RNS
Selected for European Cancer ID Programme
26 Jan 2017 07:01 AM
RNS
Interim Evaluation of Ovarian Cancer Study
26 Jan 2017 07:00 AM
RNS
Interim Results
04 Jan 2017 07:00 AM
RNS
Notice of Results
28 Nov 2016 07:00 AM
RNS
ISSUE OF SHARE OPTIONS
24 Nov 2016 02:48 PM
RNS
Result of GM
04 Nov 2016 07:00 AM
RNS
Barts Research Supports Potential Use of Parsortix
01 Nov 2016 07:00 AM
RNS
Notice of GM
27 Oct 2016 07:00 AM
RNS
Director's share purchase
07 Oct 2016 11:57 AM
RNS
Holding(s) in Company
04 Oct 2016 04:35 PM
RNS
Result of AGM
30 Sep 2016 07:00 AM
RNS
Research published in Clinical Chemistry
19 Sep 2016 11:14 AM
RNS
Issue of Equity
09 Sep 2016 04:12 PM
RNS
Annual Report and Accounts and Notice of AGM

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100